Figure S10 from Preclinical Antitumor Efficacy of a Novel Anti–c-Kit Antibody–Drug Conjugate, NN3201, in c-Kit–Positive Tumors
Abstract
Antitumor activity of NN3201 in various c-Kit expressing cancers, AML and mastocytoma
Fields of Study & Subjects
Mast cells and histamine
Gastrointestinal Tumor Research and Treatment
Chemokine receptors and signaling
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026